Back to results
US 11,530,209 B2Granted
Small molecule inhibition of transcription factor SALL4 and uses thereof
AssigneesDana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc.
InventorsJun Qi, Anthony Varca, Li Chai
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds that interrupt the function of SALL4. Also described are pharmaceutical compositions and medical uses of these compounds.
Claims22
A compound having a structure of Formula I or a pharmaceutically acceptable salt thereof:
- wherein
- Z is CR3;
- R1 is
- optionally
- substituted cycloalkyl, heterocyclyl, aryl, oxazolyl, indolyl, benzoisoxazolyl, indazolyl, azaindolyl, benzothiazolyl, imidazo[1,2-a]pyridine, or thiazolyl, wherein the optionally substituted aryl is optionally substituted phenanthrenyl or naphthalenyl substituted with one or more groups selected from hydroxyl and nitro;
- R2 is optionally substituted alkyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl;
- and
- R3 is H or optionally substituted alkyl, carboxy or ester, provided when R1 is cycloalkyl, aryl, heterocyclyl, or heteroaryl and R2 is optionally substituted alkyl, R3 is not alkyl.
5 more elements
A compound selected from
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.